Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

NCT04998201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

DRUG: ARO-APOC3
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals